Priyathama Vellanki
Overview
Explore the profile of Priyathama Vellanki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1014
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zaveri S, Stecenko A, Hunt W, Goss A, Sharma P, Hartman T, et al.
BMJ Open
. 2024 Dec;
14(12):e092503.
PMID: 39725418
Introduction: People with cystic fibrosis (PwCF) are at high risk for developing cystic fibrosis (CF)-related diabetes (CFRD), which worsens morbidity and mortality. Although the pathological events leading to the development...
2.
Umpierrez G, Castro-Revoredo I, Moazzami B, Nayberg I, Zabala Z, Galindo R, et al.
Endocr Pract
. 2024 Dec;
31(3):286-291.
PMID: 39694328
Objective: The benefits of continuous glucose monitoring (CGM) in managing hyperglycemia in hospitalized patients with type 2 diabetes (T2D) have been documented in observation and intervention clinical studies. However, the...
3.
Hirsch I, Draznin B, Buse J, Raghinaru D, Spanbauer C, Umpierrez G, et al.
Diabetes Care
. 2024 Nov;
48(1):118-124.
PMID: 39571106
Objective: To evaluate whether continuous glucose monitoring (CGM) could assist providers in intensifying glycemic management in hospitalized patients with type 2 diabetes. Research Design And Methods: At six academic hospitals,...
4.
Vellanki P, Umpierrez G
Diabetes Care
. 2024 Jul;
47(8):e63-e64.
PMID: 39052906
No abstract available.
5.
Ridout S, Vellanki P, Nemenman I
bioRxiv
. 2024 Jun;
PMID: 38895272
Ketosis-prone diabetes mellitus (KPD) is a subtype of type 2 diabetes, which presents much like type 1 diabetes, with dramatic hyperglycemia and ketoacidosis. Although KPD patients are initially insulin-dependent, after...
6.
Stefanovski D, Smiley D, Punjabi N, Umpierrez G, Vellanki P
J Clin Endocrinol Metab
. 2024 May;
PMID: 38739548
Context: Glucose tolerance during an oral glucose tolerance test (OGTT) is affected by variations in glucose effectiveness (GE) and glucose absorption and thus affects minimal model calculations of insulin sensitivity...
7.
Idrees T, Castro-Revoredo I, Oh H, Gavaller M, Zabala Z, Moreno E, et al.
J Am Med Dir Assoc
. 2024 Mar;
25(5):884-888.
PMID: 38460943
Objectives: To evaluate the efficacy of real-time continuous glucose monitoring (rt-CGM) in adjusting insulin therapy in long-term care facilities (LTCF). Design: Prospective randomized clinical trial. Settings And Participants: Insulin-treated patients...
8.
Kaminski C, Galindo R, Navarrete J, Zabala Z, Moazzami B, Gerges A, et al.
Diabetes Care
. 2023 Dec;
47(2):267-271.
PMID: 38085705
Objective: Patients with diabetes and end-stage kidney disease (ESKD) may experience "burnt-out diabetes," defined as having an HbA1c value <6.5% without antidiabetic therapy for >6 months. We aim to assess...
9.
Daley T, Cousineau B, Nesbeth P, Ivie E, Bellissimo M, Easley K, et al.
Front Nutr
. 2023 Oct;
10:1158452.
PMID: 37799765
Objective: Poor diet quality contributes to metabolic dysfunction. This study aimed to gain a greater understanding of the relationship between dietary macronutrient quality and glucose homeostasis in adults with cystic...
10.
Galindo R, Moazzami B, Scioscia M, Zambrano C, Albury B, Saling J, et al.
Diabetes Care
. 2023 Jul;
46(9):1640-1645.
PMID: 37459574
Objective: In participants with type 2 diabetes (T2D) and HbA1c >9.0-10.0%, guidelines recommend treatment with basal-bolus insulin. Research Design And Methods: This randomized trial compared the efficacy and safety of...